We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Government announces over £20 million to improve prostate cancer research and treatment, including improving access to a major trial for Black men.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Equality impact assessment of the introduction of targeted screening for prostate cancer.
This document contains a synopsis of causation occurring in cancer of the prostate.
The 12-week public consultation that opened on Friday 28 November 2025 has closed.
The Advisory Committee on Releases to the Environment's advice on an application for a trial of a genetically modified cancer vaccine.
As with all products, the MHRA will keep its safety under close review.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).